Anti-inflammatory effects of trans-anethole in a mouse model of chronic obstructive pulmonary disease

Ka Young Kim, Hui Su Lee, Geun Hee Seol

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that is generally characterized by progressive and irreversible airflow obstruction and alveolar destruction. Long-term treatment with current medications has been associated with various adverse effects, indicating a need for alternative approaches for the prevention and treatment of COPD. This study investigated the mechanism underlying the effects of trans-anethole in a mouse model of COPD induced by porcine pancreatic elastase (PPE) and lipopolysaccharide (LPS). BALB/c mice were orally administered trans-anethole (62.5, 125, 250, or 500 mg/kg) 2 h before intranasal challenge with 1.2 units of PPE and 7 μg of LPS. Lactate dehydrogenase (LDH) activity, cell counts, lung histology, cytokine production, and blood pressure were analyzed. Trans-anethole reduced LDH activity and inflammatory cell counts, including macrophage, neutrophil, and lymphocyte counts. trans-anethole 125 mg/kg restored the histopathological changes induced in mouse lungs by PPE and LPS. trans-anethole reduced the serum concentrations of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), as well as significantly reducing blood pressure during chronic inflammation. Trans-anethole ameliorated chronic lung inflammation in a mouse model of COPD by reducing the serum concentrations of pro-inflammatory cytokines such as TNF-α and IL-6, and by reducing blood pressure. The present results indicate that trans-anethole may be a potential therapeutic agent for prophylaxis and treatment in patients with chronic lung inflammation.

Original languageEnglish
Pages (from-to)925-930
Number of pages6
JournalBiomedicine and Pharmacotherapy
Volume91
DOIs
Publication statusPublished - 2017 Jul 1

Fingerprint

Chronic Obstructive Pulmonary Disease
Anti-Inflammatory Agents
Pancreatic Elastase
Lipopolysaccharides
Swine
Cytokines
Blood Pressure
L-Lactate Dehydrogenase
Interleukin-6
Pneumonia
Tumor Necrosis Factor-alpha
Cell Count
Lung
Lymphocyte Count
Therapeutics
anethole
Serum
Lung Diseases
Histology
Neutrophils

Keywords

  • Blood pressure
  • Chronic obstructive pulmonary disease (COPD)
  • Interleukin-6 (IL-6)
  • Lipopolysaccharide (LPS)
  • Porcine pancreatic elastase (PPE)
  • Trans-anethole

ASJC Scopus subject areas

  • Pharmacology

Cite this

Anti-inflammatory effects of trans-anethole in a mouse model of chronic obstructive pulmonary disease. / Kim, Ka Young; Lee, Hui Su; Seol, Geun Hee.

In: Biomedicine and Pharmacotherapy, Vol. 91, 01.07.2017, p. 925-930.

Research output: Contribution to journalArticle

@article{7f340639c35b471696f159c713605d68,
title = "Anti-inflammatory effects of trans-anethole in a mouse model of chronic obstructive pulmonary disease",
abstract = "Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that is generally characterized by progressive and irreversible airflow obstruction and alveolar destruction. Long-term treatment with current medications has been associated with various adverse effects, indicating a need for alternative approaches for the prevention and treatment of COPD. This study investigated the mechanism underlying the effects of trans-anethole in a mouse model of COPD induced by porcine pancreatic elastase (PPE) and lipopolysaccharide (LPS). BALB/c mice were orally administered trans-anethole (62.5, 125, 250, or 500 mg/kg) 2 h before intranasal challenge with 1.2 units of PPE and 7 μg of LPS. Lactate dehydrogenase (LDH) activity, cell counts, lung histology, cytokine production, and blood pressure were analyzed. Trans-anethole reduced LDH activity and inflammatory cell counts, including macrophage, neutrophil, and lymphocyte counts. trans-anethole 125 mg/kg restored the histopathological changes induced in mouse lungs by PPE and LPS. trans-anethole reduced the serum concentrations of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), as well as significantly reducing blood pressure during chronic inflammation. Trans-anethole ameliorated chronic lung inflammation in a mouse model of COPD by reducing the serum concentrations of pro-inflammatory cytokines such as TNF-α and IL-6, and by reducing blood pressure. The present results indicate that trans-anethole may be a potential therapeutic agent for prophylaxis and treatment in patients with chronic lung inflammation.",
keywords = "Blood pressure, Chronic obstructive pulmonary disease (COPD), Interleukin-6 (IL-6), Lipopolysaccharide (LPS), Porcine pancreatic elastase (PPE), Trans-anethole",
author = "Kim, {Ka Young} and Lee, {Hui Su} and Seol, {Geun Hee}",
year = "2017",
month = "7",
day = "1",
doi = "10.1016/j.biopha.2017.05.032",
language = "English",
volume = "91",
pages = "925--930",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Anti-inflammatory effects of trans-anethole in a mouse model of chronic obstructive pulmonary disease

AU - Kim, Ka Young

AU - Lee, Hui Su

AU - Seol, Geun Hee

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that is generally characterized by progressive and irreversible airflow obstruction and alveolar destruction. Long-term treatment with current medications has been associated with various adverse effects, indicating a need for alternative approaches for the prevention and treatment of COPD. This study investigated the mechanism underlying the effects of trans-anethole in a mouse model of COPD induced by porcine pancreatic elastase (PPE) and lipopolysaccharide (LPS). BALB/c mice were orally administered trans-anethole (62.5, 125, 250, or 500 mg/kg) 2 h before intranasal challenge with 1.2 units of PPE and 7 μg of LPS. Lactate dehydrogenase (LDH) activity, cell counts, lung histology, cytokine production, and blood pressure were analyzed. Trans-anethole reduced LDH activity and inflammatory cell counts, including macrophage, neutrophil, and lymphocyte counts. trans-anethole 125 mg/kg restored the histopathological changes induced in mouse lungs by PPE and LPS. trans-anethole reduced the serum concentrations of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), as well as significantly reducing blood pressure during chronic inflammation. Trans-anethole ameliorated chronic lung inflammation in a mouse model of COPD by reducing the serum concentrations of pro-inflammatory cytokines such as TNF-α and IL-6, and by reducing blood pressure. The present results indicate that trans-anethole may be a potential therapeutic agent for prophylaxis and treatment in patients with chronic lung inflammation.

AB - Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that is generally characterized by progressive and irreversible airflow obstruction and alveolar destruction. Long-term treatment with current medications has been associated with various adverse effects, indicating a need for alternative approaches for the prevention and treatment of COPD. This study investigated the mechanism underlying the effects of trans-anethole in a mouse model of COPD induced by porcine pancreatic elastase (PPE) and lipopolysaccharide (LPS). BALB/c mice were orally administered trans-anethole (62.5, 125, 250, or 500 mg/kg) 2 h before intranasal challenge with 1.2 units of PPE and 7 μg of LPS. Lactate dehydrogenase (LDH) activity, cell counts, lung histology, cytokine production, and blood pressure were analyzed. Trans-anethole reduced LDH activity and inflammatory cell counts, including macrophage, neutrophil, and lymphocyte counts. trans-anethole 125 mg/kg restored the histopathological changes induced in mouse lungs by PPE and LPS. trans-anethole reduced the serum concentrations of pro-inflammatory cytokines, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), as well as significantly reducing blood pressure during chronic inflammation. Trans-anethole ameliorated chronic lung inflammation in a mouse model of COPD by reducing the serum concentrations of pro-inflammatory cytokines such as TNF-α and IL-6, and by reducing blood pressure. The present results indicate that trans-anethole may be a potential therapeutic agent for prophylaxis and treatment in patients with chronic lung inflammation.

KW - Blood pressure

KW - Chronic obstructive pulmonary disease (COPD)

KW - Interleukin-6 (IL-6)

KW - Lipopolysaccharide (LPS)

KW - Porcine pancreatic elastase (PPE)

KW - Trans-anethole

UR - http://www.scopus.com/inward/record.url?scp=85019224448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019224448&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.05.032

DO - 10.1016/j.biopha.2017.05.032

M3 - Article

VL - 91

SP - 925

EP - 930

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

ER -